PillPosaconazole
Brands: Noxafil · Posaconazole
3 active makers
soon
soon
soon
soon
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
Who makes it3 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Endo USA, Inc. | unknown | 1 | SUPPLYING |
| Hikma Pharmaceuticals USA Inc. | unknown | 1 | SUPPLYING |
| Merck Sharp & Dohme LLC. | unknown | 1 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Dec 12, 2025RECALLRecall (Class II): Noxafil Powdermix (posaconazole) for Delayed-Release Oral Suspension, 300 mg, 8 packets per carton, Rx Only, Manufactur…
Presence of particulate matter: potential presence of metal particulates in the product. — Recalling firm: Merck Sharp & Dohme LLC — Nationwide in the USA
- Dec 2, 2025RESOLVEDShortage resolved: Posaconazole Injection (Merck Sharp & Dohme Corp.)
Posaconazole Injection — reported in shortage by Merck Sharp & Dohme Corp.. Therapeutic category: Anti-Infective.
- Dec 2, 2025SHORTAGEDrug shortage: Posaconazole Injection (Merck Sharp & Dohme Corp.)
Posaconazole Injection — reported in shortage by Merck Sharp & Dohme Corp.. Therapeutic category: Anti-Infective.